The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease
Medical Advisory Board member, Dr. Ellen Sidransky, recently published an... Read more
Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit... Read more
Shire VPRIV Gaucher study
Are you an adult 18 – 65 years of age... Read more
Sanofi Genzyme Announces Torch Awards
SANOFI GENZYME – We are proud to announce the first... Read more
New York Conference Raises Awareness for Gaucher Disease
As a culmination of Gaucher Awareness Month, on October 30,... Read more
Gaucher Disease and Parkinson: An Opportunity to Participate in a Study
Researchers have linked Gaucher disease to a slightly increased risk... Read more
Sanofi Genzyme announces “Seven Tests for Managing Gaucher”
It’s important to monitor Gaucher disease with regular assessments. For... Read more
NGF Mourns the Loss of Dr. Roscoe Brady
Summary: The National Gaucher Foundation today mourns the passing of... Read more
New Gaucher research protocol enrolling participants
Are you an adult 18 – 65 years of age... Read more
Helping kids battle a rare disease
In the blink of an eye, life completely changed for... Read more
